AdBIOPRO, Competence Centre for Advanced Bioproduction by Continuous Processing, aims to become a leading international center for research and development in bioproduction technologies. The goal is to enable large scale production of biological therapies. AdBIOPRO is financed by VINNOVA, Sweden's innovation agency, with 28,5 million SEK during 2017-2022 The Competence Center currently consists of 7 industry partners, 1 hospital and 2 universities in close collaboration. Companies are SOBI, Cobra Biologics, Cytiva (former GE Healthcare), CellProtect, Lab-on-a-Bead, BioInvent and Valneva. Karolinska Hospital, KTH and Lund Universty are non-industrial partners. AdBIOPRO is an important resource for Swedish biomedical industry, as well as for academic institutions. Academical partners, lead by KTH, The Royal Institute of Technology, are world-leading in areas of bioprocess technologies for mammalian cell production, omics characterization, protein purification, gene therapy and data-driven modelling och process control. This enables AdBIOPPRO to focus on the imminent technology shift from batch to continuous processes and production of biological therapeutics.